How do you pay?
How many capsules?

How to pay the least

Lowest price

$80.80 for 30 capsules delivered ($75.55 plus $5.25 shipping)

Generic trientine 250 mg from Cost Plus Drugs, by mail

What to do

  1. Make a free account on costplusdrugs.com. Ask your prescriber to send the prescription there, or Cost Plus Drugs can transfer it.Open Cost Plus Drugs 
  2. Order generic trientine 250 mg. It comes by mail.

A regular generic has the same active ingredient as Syprine, and the FDA requires it to work the same way.

See every pharmacy’s price

Compare every option

Brand name

Syprine, the original

Cash priceAsk the pharmacyUsually the highest price

We didn’t find a savings card or cash price from Syprine’s maker. Ask the pharmacy for Syprine’s cash price. With insurance, ask what your plan charges.

Authorized generic

One was sold before, but not anymore.

Not soldNo longer sold

Regular generic

Same active ingredient as Syprine. Fillers and dyes can differ.

Lowest$80.80for 30 capsules at Cost Plus Drugs, with shipping
Where to buy it and who makes it

Where to buy it

Pharmacies’ own cash prices for generic trientine, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 17, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Who makes it

4 companies sell a generic of Syprine that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Camber Pharmaceuticals250 mg

    Has dyes: D&C Red No. 28, FD&C Blue No. 1 · Made by Hetero Labs

    Product page on camberpharma.com

    How it looks, what’s in it, NDCs

    250 mg Opaque, capsule, 20 mm, marked “H / T4”

    PackageNDC
    Carton of 10031722-683-01

    Inactive ingredients: stearic acid, D&C Red No. 28, FD&C Blue No. 1, gelatin, titanium dioxide, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, ammonia

    FDA label

  • Dr. Reddy’s Laboratories250 mg
    How it looks, what’s in it, NDCs

    250 mg Yellow opaque, capsule, 19 mm, marked “RDY / 459”

    PackageNDC
    Bottle of 10043598-459-01

    Inactive ingredients: silicon dioxide, ferric oxide yellow, gelatin, magnesium stearate, polyethylene glycol, titanium dioxide, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac

    FDA label

  • Novadoz Pharmaceuticals250 mg

    Made by MSN Laboratories

    Product page on novadozpharma.com

    How it looks, what’s in it, NDCs

    250 mg Light brown, capsule, 19 mm, marked “250 / TRN”

    PackageNDC
    Carton of 10072205-008-91

    Inactive ingredients: gelatin, stearic acid, titanium dioxide, ferric oxide red, ferric oxide yellow, shellac, propylene glycol, potassium hydroxide, ferrosoferric oxide

    FDA label

  • Rising Pharma Holdings250 mg
    How it looks, what’s in it, NDCs

    250 mg Brown opaque, capsule, 19 mm, marked “C27 / 250mg”

    PackageNDC
    Bottle of 10016571-810-01

    Inactive ingredients: gelatin, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, stearic acid, titanium dioxide

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

Syprine is indicated in the treatment of patients with Wilson’s disease who are intolerant of penicillamine. Clinical experience with Syprine is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient’s dose have not been well defined. Syprine and penicillamine cannot be considered interchangeable. Syprine should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects.

Unlike penicillamine, Syprine is not recommended in cystinuria or rheumatoid arthritis. The absence of a sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. In 15 patients with rheumatoid arthritis, Syprine was reported not to be effective in improving any clinical or biochemical parameter after 12 weeks of treatment.

Syprine is not indicated for treatment of biliary cirrhosis.

Source: the FDA label for Syprine (Bausch Health US LLC), September 1, 2020. Full label on DailyMed